Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial

Bernstein, E. J., Denton, C. P., Huang, S., & Khanna, D. (2024). Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial. Seminars in Arthritis and Rheumatism, 65, 152376. https://doi.org/10.1016/j.semarthrit.2024.152376
Authors:
Elana J Bernstein
Christopher P Denton
Suiyuan Huang
Dinesh Khanna
Affiliated Authors:
Elana J Bernstein
Columbia Affiliation:
Subjects:
Lung Diseases, Interstitial (MeSH)
Scleroderma, Systemic (MeSH)
Author Keywords:
systemic sclerosis
interstitial lung disease
monocytes
tocilizumab
elink
Publication Type:
Article
Unique ID:
10.1016/j.semarthrit.2024.152376
PMID:
38244446
DOI:
10.1016/j.semarthrit.2024.152376
Journal:
Seminars in Arthritis and Rheumatism
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: